FDA clears Roche's CoaguChek XS Pro
This article was originally published in Clinica
Executive Summary
Roche Diagnostics' latest point-of-care (POC) anticoagulation monitor, the CoaguChek XS Pro, has received 510(k) clearance from the US FDA. The device assesses prothrombin time (PT) and the international normalised ratio (INR), which are measures of blood clotting tendency. This information can be used to adjust doses of the anticoagulant drug warfarin. The meter has a built-in bar code reader that can automatically scan information to identify operators and patients, in conjunction with the firm's RALS-Plus information management system. This could prevent the errors sometimes generated when clinicians manually enter information on PT/INR, Roche says. The system requires 8 microlitres of blood, and can provide results in around one minute, the firm added.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.